Gonadotropin-releasing hormone agonist for oocyte triggering in endometrial preparation of letrozole stimulation protocols does not affect clinical outcome of frozen-thawed embryo transfer

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 10, 2015, Pages 19072-19078

  Huang, Pin Xiu ^a   Wei, Ji Hong ^a   Wei, Li Hong ^a  

^a Liuzhou Municipal Maternity and Child Healthcare Hospital   (China)

Author keywords

Frozen thawed embryo transfer; Gonadotropin releasing hormone agonist; HCG; Letrozole

Indexed keywords

GONADORELIN AGONIST; LETROZOLE; PROGESTERONE;

ADULT; ARTICLE; EMBRYO; EMBRYO TRANSFER; ENDOMETRIAL THICKNESS; ESTRUS CYCLE; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FREEZE THAWING; HUMAN; HUMAN CELL; LIVE BIRTH; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OOCYTE MATURATION; OUTCOME ASSESSMENT; PREGNANCY RATE; PROGESTERONE BLOOD LEVEL; SPONTANEOUS ABORTION; TREATMENT OUTCOME;

EID: 84949681341     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kessler MJ, Reddy MS, Shah RH, Bahl OP. Structure of N-glycosidic carbohydrate units of human chorionic gonadotropin. J Biol Chem 1979; 254: 7901-7908.
2. Cerrillo M, Pacheco A, Rodríguez S, et al. Differential regulation of VEGF, Cadherin, and Angiopietin 2 by trigger oocyte maturation with GnRHa vs hCG in donors: try to explain the lower OHSS incidence. In: Abstracts of the 25th annual meeting of the ESHRE. Amsterdam: 2009. vol. 24. p. i60.
3. Griesinger G, Kolibianakis EM, Papanikolaou EG, Diedrich K, Van Steirteghem A, Devroey P, Ejdrup Bredkjaer H, Humaidan P. Triggering of final oocyte maturation with gonadotropinreleasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles. Fertil Steril 2007; 88: 616-621.
4. Griesinger G, Diedrich K, Devroey P, Kolibi-anakis EM. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update 2006; 12: 159-168.
5. Babayof R, Margalioth EJ, Huleihel M, Amash A, Zylber-Haran E, Gal M, Brooks B, Mimoni T, Eldar-Geva T. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial. Hum Reprod 2006; 21: 1260-1265.
6. Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril 2008; 89: 84-91.
7. Youssef MA, Abdelmoty HI, Ahmed MA, Elmohamady M. GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis. J Adv Res 2015; 6: 341-349.
8. Youssef MA, Van der Veen F, Al-Inany HG, Mochtar MH, Griesinger G, Nagi Mohesen M, Aboulfoutouh I, van Wely M. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted repro-ductive technology. Cochrane Database Syst Rev 2014; 10: CD008046.
9. Youssef MA, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, Aboulfoutouh I, Khattab SM, van Wely M. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database Syst Rev 2011; 19: CD008046.
10. Humaidan P, Bredkjaer HE, Bungum L, Bungum M, Grøndahl ML, Westergaard L, Andersen CY. GnRH agonist (Buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomised study. Hum Reprod 2005; 20: 1213-1220.
11. Humaidan P, Papanikolaou EG, Kyrou D, Alsbjerg B, Polyzos NP, Devroey P, Fatemi HM. The luteal phase after GnRHagonist triggering of ovulation: present and future perspectives. Reproductive Bio Medicine Online 2012; 24: 134-141.
12. Pirard C, Donnez J, Loumaye E. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study. Hum Reprod 2006; 21: 1894-900.
13. Engmann L, DiLuigi A, Schmidt D, et al. The use of gonadotropin-releasing hormone (Gn-RH) agonistprospective randomized controlled study. Fertil Steril 2008; 89: 84-91.
14. Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. 1500 IU hCG secures a normal clinical pregnancy outcome in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist. Fertil Steril 2010; 93: 847-54.
15. Palomino WA, Fuentes A, González RR, Gabler F, Boric MA, Vega M, Devoto L. Differential ex-pression of endometrial integrins and progesterone receptor during the window of implantation in normo-ovulatory women treated with clomiphene citrate. Fertil Steril 2005; 83: 587-93.
16. Nelson LM, Hershlag A, Kurl RS, Hall JL, Stillman RJ. Clomiphene citrate directly Impairs endometrial receptivity in the mouse. Fertil Steril 1990; 53: 727-31.
17. Geng Q, Guo S, Quan S, Xing F. Clinical observation of effects on follicular development and endometrium with letrozole for ovulation. Pract Med 2010; 26: 2209-2211.
18. Badawy A, Abdel Aal I, Abulatta M. Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial. Fertil Steril 2009; 92: 849-852.
19. Bao SH, Sheng SL, Peng YF, Lin QD. Effects of letrozole and clomiphene citrate on the expression of HOXA10 and integrin avb3 in uterine epithelium of rats. Fertil Steril 2009; 91: 244-248.
20. Li SJ, Zhang YJ, Chai XS, Nie MF, Zhou YY, Chen JL, Tao GS. Letrozole ovulation induction: an effective option in endometrial preparation for frozen-thawed embryo transfer. Arch Gynecol Obstet 2014; 289: 687-93.
21. Hu YJ, Chen YZ, Zhu YM, Huang HF. Letrozole stimulation in endometrial preparation for cryopreserved-thawed embryo transfer in women withpolycystic ovarian syndrome: a pilot study. Clin Endocrinol (Oxf) 2014; 80: 283-9.
22. Schmidt-Sarosi C, Kaplan DR, Sarosi P, Essig MN, Licciardi FL, Keltz M, Levitz M. Ovulation triggering in Clomiphene Citrate-stimulated cycles: human chorionic gonadotrophin versus a gonadotrophin releasing hormone agonist. J Assist Reprod Genet 1995; 12: 167-74.
23. Romeu A, Monzó A, Peiró T, Diez E, Peinado JA, Quintero LA. Endogenous LH surge versus hCG as ovulation trigger after low-dose highly purified FSH in IUI: a comparison of 761 cycles. J Assist Reprod Genet 1997; 14: 518-24.
24. Lee JI, Hur YM, Jeon ES, et al. Comparison of pregnancy rates by intrauterine insemination after ovulation trigger with endogenous LH surge, GnRH agonist or hCG in stimulated cycles. Korean J Fertil Steril 1999; 26: 389-98.
25. Badeea S Soliman, Soha Siam. Pregnancy rate after ovulation triggering with gonadotrophin releasing hormone agonist versus human chorionic gonadotrophin in women undergoing controlled ovarian stimulation/intrauterine insemination. Middle East Fertility Society Journal 2014; 9: 262-267.
26. Shalev E, Geslevich Y, Matilsky M, Ben-Ami M. Gonadotrophin-releasing hormone agonist compared with human chorionic gonadotrophin for ovulation induction after clomiphene citrate treatment. Hum Reprod 1995; 10: 2541-4.
27. Rath SK, Sharma RK. Use of gonadotrophin releasing hormone agonist instead of human chorionic gonadotrophin for triggering ovulation. J Obstet Gynecol Ind 2004; 54: 383-6.
28. Schmidt-Sarosi C, Kaplan DR, Sarosi P, Essig MN, Licciardi FL, Keltz M, Levitz M. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist. J Assist Reprod Genet 1995; 12: 167-74.
29. Youssef MA, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, van Wely M. Gona-dotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assist-ed reproductive technology cycles. Cochrane Database Syst Rev 2010; CD008046.
30. Youssef MA, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, Aboulfoutouh I, Khattab SM, van Wely M. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database Syst Rev 2011; 19: CD008046.